Neutrogena Rapid Clear 2 in 1 Fight and Fade Toner

Description

NEUTORGENA Rapid Clear 2-in-1 Fight & Fade Toner utilizes MICRO CLEAR® technology to effectively combat breakouts within 8 hours while also diminishing the appearance of post-acne marks. This formulation includes Neutrogena® salicylic acid as an active ingredient, providing targeted acne treatment. The product is available in an 8 FL. OZ. (236 mL) dosage form.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleansed prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer. This can be done one to three times daily, depending on the patient's needs and response to treatment.

To minimize the risk of excessive drying of the skin, it is advisable to initiate treatment with one application per day. Based on the patient's tolerance and as directed by a physician, the frequency may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to once daily or every other day to alleviate these side effects.

Contraindications

There are no specific contraindications listed for this product. However, it is essential to keep the product out of reach of children. In the event of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

Skin irritation and dryness may be exacerbated if this product is used concurrently with other topical acne medications. It is recommended that only one topical acne medication be used at a time to minimize the risk of irritation. Healthcare professionals should monitor patients for signs of skin irritation and advise them to discontinue use if such symptoms occur.

In the event of eye contact, it is imperative to flush the eyes thoroughly with water to mitigate potential damage.

This product should be stored out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. This product is intended for external use only and is flammable; therefore, it should be kept away from fire or flame.

Common adverse reactions include skin irritation and dryness, which are more likely to occur if another topical acne medication is used concurrently. In such cases, it is advised that patients use only one topical acne medication at a time to minimize the risk of irritation.

In the event of eye contact, patients should flush the affected area thoroughly with water to mitigate any potential adverse effects.

Additionally, if the product is swallowed, it is crucial to seek medical assistance or contact a Poison Control Center immediately. These precautions are essential to ensure the safe use of the product and to address any adverse reactions that may arise.

Drug Interactions

Concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one at a time to minimize the potential for adverse effects. If irritation occurs, the patient should discontinue the use of additional topical acne medications and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Neutrogena Rapid Clear 2 in 1 Fight and Fade Toner (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of Neutrogena Rapid Clear 2-in-1 Fight & Fade Toner in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when recommending this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of the patient's response to treatment.

Pregnancy

The safety of this product during pregnancy has not been established. The use of salicylic acid during pregnancy is generally not recommended due to potential risks to the fetus. Pregnant patients or those planning to become pregnant should consult a healthcare provider before using this product to discuss potential risks and benefits.

Lactation

There are no specific statements regarding the use of this medication in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of data does not preclude the need for careful evaluation of each patient's unique circumstances.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Patients should be made aware that using this medication in conjunction with other topical acne treatments may increase the likelihood of skin irritation and dryness. It is important to counsel patients to use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, healthcare providers should inform patients about the importance of avoiding eye contact with the medication. In case of accidental eye exposure, patients should be instructed to flush the eyes thoroughly with water to ensure safety.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers assigned for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted; however, standard precautions should be observed to ensure optimal storage conditions.

Additional Clinical Information

The product is administered topically. Clinicians should counsel patients regarding the potential for increased skin sensitivity to the sun due to the presence of an alpha hydroxy acid (AHA) in the formulation. Patients are advised to use sunscreen, wear protective clothing, and limit sun exposure while using the product and for one week following its use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Neutrogena Rapid Clear 2 in 1 Fight and Fade Toner, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)